Korean Academy of Medical Sciences and Pfizer Korea Open Pfizer Medical Award Nominations... 50 Million Won Prize in Each Category

Applications Open in Three Categories: Basic, Clinical, and Translational Medicine

Submit by July 31

Papers Published in the Past Two Years Eligible

Total Prize Fund of 150 Million Won

The Korean Academy of Medical Sciences and Pfizer Korea announced on May 28 that they are accepting nominations for the 24th Pfizer Medical Award until July 31.

2026 Pfizer Medical Award Promotional Material. Pfizer Korea

The Pfizer Medical Award is an academic prize in the field of pure medicine, organized by the Korean Academy of Medical Sciences and sponsored by Pfizer Korea. Established in 1999, the award aims to discover medical scientists who have contributed to the advancement of medicine and the promotion of public health. To date, Pfizer Korea has selected and supported a total of 58 medical scientists.

This year's call for nominations will be conducted in three categories: basic medicine, clinical medicine, and translational medicine. One paper will be selected from each field, for a total of three papers. Each awardee will receive 50 million won in prize money and a plaque. The total prize fund amounts to 150 million won.

Eligible applicants are medical scientists who hold a medical license of the Republic of Korea or who are affiliated with a medical school or graduate school of medicine in Korea. The submitted paper must be a research article published in a domestic or international pure academic journal between August 1, 2024 and July 31, 2026.

Applicants must submit one main paper, up to five related papers published within the last five years, an application form, a curriculum vitae, and a letter of recommendation. Papers that have already received awards domestically or internationally, or are currently under review for awards, are not eligible.

All required documents must be submitted by email to the Pfizer Medical Award Steering Committee of the Korean Academy of Medical Sciences by 6:00 p.m. on July 31. The award ceremony is scheduled to be held on November 4.

Han Sangwon, President of the Korean Academy of Medical Sciences, stated, "We have contributed to the spread of academic value in domestic medical research by discovering outstanding research achievements."

Oh Dongwook, CEO of Pfizer Korea, said, "We will continue to support innovative research achievements by Korean medical scientists so they can lead to improved patient care."

This content was produced with the assistance of AI translation services.